Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect

被引:33
作者
Kewalramani, VN
Park, CS
Gallombardo, PA
Emerman, M
机构
[1] FRED HUTCHINSON CANC RES CTR,DIV MOLEC MED,SEATTLE,WA 98104
[2] FRED HUTCHINSON CANC RES CTR,DIV BASIC SCI,SEATTLE,WA 98104
[3] UNIV WASHINGTON,PROGRAM MOLEC & CELLULAR BIOL,SEATTLE,WA 98195
[4] UNIV WASHINGTON,DEPT MICROBIOL,SEATTLE,WA 98195
关键词
D O I
10.1006/viro.1996.0201
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Using recombinant proteins as standards, we calculated the amount of Vpr and Vpx present in HIV-2(ROD) particles. We find 2000-3000 copies of Vpx per particle but only 40-50 copies of Vpr. We investigated the reasons for this discrepancy between Vpx and Vpr and found that viral factors, including HIV-2 Vpx, do not restrict its incorporation. Instead, the accumulation of HIV-2(ROD) Vpr during infection is restricted by a short protein half-life which acts to limit its virion incorporation. The half-life of HIV-2 Vpr was calculated to be about 90 min, while HIV-2 Vpx and HIV-1 Vpr had half-lifes of 36 and 20 hr, respectively. Moreover, while both HIV-1 Vpr and HIV-2 Vpr cause cells to accumulate in G2 of the cell cycle, the effect of HIV-2 Vpr is attenuated relative to HIV-1 Vpr. Thus, protein stability correlates with both the function of Vpr and its Virion incorporation. (C) 1996 Academic Press, Inc.
引用
收藏
页码:326 / 334
页数:9
相关论文
共 38 条
[1]   RAPID VIRUS SUBUNIT VISUALIZATION BY DIRECT SEDIMENTATION OF SAMPLES ON ELECTRON-MICROSCOPE GRIDS [J].
ALAIN, R ;
NADON, F ;
SEGUIN, C ;
PAYMENT, P ;
TRUDEL, M .
JOURNAL OF VIROLOGICAL METHODS, 1987, 16 (03) :209-216
[2]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[3]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS AS A PROTOTYPIC COMPLEX RETROVIRUS [J].
CULLEN, BR .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1053-1056
[5]   PROPERTIES OF A RIBONUCLEOPROTEIN PARTICLE ISOLATED FROM NONIDET P-40-TREATED ROUS-SARCOMA VIRUS [J].
DAVIS, NL ;
RUECKERT, RR .
JOURNAL OF VIROLOGY, 1972, 10 (05) :1010-1020
[6]   VIRAL PROTEIN-R OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 IS DISPENSABLE FOR REPLICATION AND CYTOPATHOGENICITY IN LYMPHOID-CELLS [J].
DEDERA, D ;
HU, W ;
VANDERHEYDEN, N ;
RATNER, L .
JOURNAL OF VIROLOGY, 1989, 63 (07) :3205-3208
[7]   MUTATIONAL ANALYSIS OF CELL-CYCLE ARREST, NUCLEAR-LOCALIZATION, AND VIRION PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR [J].
DIMARZIO, P ;
CHOE, S ;
EBRIGHT, M ;
KNOBLAUCH, R ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7909-7916
[8]   THE REV GENE-PRODUCT OF THE HUMAN IMMUNODEFICIENCY VIRUS AFFECTS ENVELOPE-SPECIFIC RNA LOCALIZATION [J].
EMERMAN, M ;
VAZEUX, R ;
PEDEN, K .
CELL, 1989, 57 (07) :1155-1165
[9]  
EMERMAN M, 1994, NATURE, V369, P107
[10]   PROGRESSION TO AIDS IN THE ABSENCE OF A GENE FOR VPR OR VPX [J].
GIBBS, JS ;
LACKNER, AA ;
LANG, SM ;
SIMON, MA ;
SEHGAL, PK ;
DANIEL, MD ;
DESROSIERS, RC .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2378-2383